MX9805063A - Nuevos derivados de acido barbiturico, procesos para su produccion y agentes farmaceuticos que contienen estos compuestos. - Google Patents
Nuevos derivados de acido barbiturico, procesos para su produccion y agentes farmaceuticos que contienen estos compuestos.Info
- Publication number
- MX9805063A MX9805063A MX9805063A MX9805063A MX9805063A MX 9805063 A MX9805063 A MX 9805063A MX 9805063 A MX9805063 A MX 9805063A MX 9805063 A MX9805063 A MX 9805063A MX 9805063 A MX9805063 A MX 9805063A
- Authority
- MX
- Mexico
- Prior art keywords
- bicycle
- monocycle
- compounds
- several times
- alkyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 239000008177 pharmaceutical agent Substances 0.000 title abstract 2
- 150000007656 barbituric acids Chemical class 0.000 title 1
- 125000005842 heteroatom Chemical group 0.000 abstract 3
- 125000002252 acyl group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 abstract 1
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 abstract 1
- 125000004648 C2-C8 alkenyl group Chemical group 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000005864 Sulphur Substances 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 abstract 1
- 125000004670 alkyl amino thio carbonyl group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000004682 aminothiocarbonyl group Chemical group NC(=S)* 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
- A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
- C07D239/62—Barbituric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
- C07D239/66—Thiobarbituric acids
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Se describen los compuestos de la formula I en la cual X, Y y Z son, independientemente uno del otro, un átomo de oxígeno, azufre o NH; R1 representa un grupo W-V; W es un enlace de valencia o un grupo de cadena lineal o ramificada de alquilo de 1 a 8 átomos de carbono o un grupo alquenilo de 2 a 8 átomos de carbono, el cual está opcionalmente una o varias veces sustituido, V es un monicongo o biciclo opcionalmente sustituido, el cual puede contener uno o varios heteroátomos, o W-V es un grupo alquilo de 1 a 20 átomos de carbono el cual puede estar interrumpido por heteroátomos, uno o varios átomos de carbono están opcionalmente sustituidos; R2 y R3 representan hidrogeno o uno de los dos representa alquilo inferior o acilo inferior; R4 y R5 denotan independientemente uno del otro A-D, en donde A representa un enlace de valencia alquilo, alquenilo, acilo, alquilsulfonilo, sulfonilo, alquilaminocarbonilo, aminocarbonilo, alcoxicarbonilo, oxi-carbonilo, alquilaminotiocarbonilo, aminotiocarbonilo el cual está opcionalmente una o varias veces sustituido; D representa un hidrogeno, monociclo o biciclo, el monociclo o el biciclo está opcionalmente interrumpido una o varias veces por heteroátomos, y el monociclo o el biciclo está sustituido una o varias veces, o R4 y R5 conjuntamente con el átomo de nitrogeno adyacente forman un anillo; las sales farmacéuticamente aceptables, y los profármacos de los mismos, y las formas opticamente activas, los procesos para su produccion y los agentes farmacéuticos que contienen estos compuestos, que tienen accion inhibitoria de la metaloproteasa de matriz.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19548624A DE19548624A1 (de) | 1995-12-23 | 1995-12-23 | Neue Barbitursäure-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9805063A true MX9805063A (es) | 1998-10-31 |
Family
ID=7781338
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9805063A MX9805063A (es) | 1995-12-23 | 1998-06-22 | Nuevos derivados de acido barbiturico, procesos para su produccion y agentes farmaceuticos que contienen estos compuestos. |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US6110924A (es) |
| EP (1) | EP0869947B1 (es) |
| JP (1) | JP4198752B2 (es) |
| KR (1) | KR100440035B1 (es) |
| CN (1) | CN1318406C (es) |
| AT (1) | ATE226575T1 (es) |
| BR (1) | BR9612232A (es) |
| CZ (1) | CZ292503B6 (es) |
| DE (2) | DE19548624A1 (es) |
| DK (1) | DK0869947T3 (es) |
| ES (1) | ES2184903T3 (es) |
| HU (1) | HUP9901065A3 (es) |
| IL (1) | IL125048A (es) |
| MX (1) | MX9805063A (es) |
| NO (1) | NO311572B1 (es) |
| NZ (1) | NZ325802A (es) |
| PL (1) | PL190217B1 (es) |
| PT (1) | PT869947E (es) |
| RU (1) | RU2177475C2 (es) |
| TW (1) | TW518324B (es) |
| WO (1) | WO1997023465A1 (es) |
| ZA (1) | ZA9610765B (es) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010014020A (ko) | 1997-06-21 | 2001-02-26 | 로셰 디아그노스틱스 게엠베하 | 항전이성 및 항종양성 활성을 갖는 바르비투르산 유도체 |
| DE19726427A1 (de) | 1997-06-23 | 1998-12-24 | Boehringer Mannheim Gmbh | Pyrimidin-2,4,6-trion-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| US6350786B1 (en) | 1998-09-22 | 2002-02-26 | Hoffmann-La Roche Inc. | Stable complexes of poorly soluble compounds in ionic polymers |
| US6265578B1 (en) * | 1999-02-12 | 2001-07-24 | Hoffmann-La Roche Inc. | Pyrimidine-2,4,6-triones |
| AR033651A1 (es) | 1999-10-01 | 2004-01-07 | Hoffmann La Roche | Derivados de pirimidina-2,4,6-triona, composiciones farmaceuticas que contienen dichos compuestos y el empleo de los mismos para la manufactura de un medicamento |
| SK4872003A3 (en) | 2000-10-26 | 2004-08-03 | Pfizer Prod Inc | Metaloproteinase pyrimidine-2,4,6-trione inhibitors |
| US6716845B2 (en) | 2001-03-30 | 2004-04-06 | Hoffmann-La Roche Inc. | Barbituric acid derivatives |
| WO2002089824A1 (en) * | 2001-05-03 | 2002-11-14 | F. Hoffmann-La Roche Ag | Combination of a gelatinase inhibitor and an anti-tumor agent, and uses thereof |
| CA2446356C (en) * | 2001-05-09 | 2012-07-10 | The Regents Of The University Of Michigan | Use of compositions for treating rosacea |
| AU2002346729A1 (en) * | 2001-12-20 | 2003-07-09 | Bristol-Myers Squibb Company | Barbituric acid derivatives as inhibitors of tnf-$g(a) converting enzyme (tace) and/or matrix metalloproteinases |
| NI200300045A (es) * | 2002-04-26 | 2005-07-08 | Pfizer Prod Inc | Inhibidores de triariloxiariloxipirimidin-2,4,6-triona de metaloproteinasa. |
| JP2006516548A (ja) | 2002-12-30 | 2006-07-06 | アンジオテック インターナショナル アクツィエン ゲゼルシャフト | 迅速ゲル化ポリマー組成物からの薬物送達法 |
| WO2004084903A1 (en) * | 2003-03-27 | 2004-10-07 | F. Hoffmann-La Roche Ag | Use of a trioxopyrimidine for the treatment and prevention of ocular pathologic angiogenesis |
| WO2004084902A1 (en) * | 2003-03-28 | 2004-10-07 | F. Hoffmann-La Roche Ag | Use of a trioxopyrimidine for the treatment of chronic wounds |
| WO2004110457A1 (en) * | 2003-06-06 | 2004-12-23 | F. Hoffmann-La Roche Ag | Matrix metalloproteinases inhibitors for the stimulation and protection of bone marrow stem cells |
| US20070191404A1 (en) * | 2004-04-01 | 2007-08-16 | Pierre Bartsch | Pharmaceutical compositions of pyrimidine-2,4,6-triones |
| AU2005230379B2 (en) * | 2004-04-01 | 2010-07-22 | Universite De Liege | Use of a trioxopyrimidine for the treatment and prevention of bronchial inflammatory diseases |
| EP1632489A1 (en) * | 2004-08-24 | 2006-03-08 | University of Liege | 5-(1,1'-Biphenyl)-4-yl-5-(4-(4-aminoacylphenyl)-piperazin)-1-yl-pyrimidine-2,4,6-trione derivatives, as inhibitors of zinc metallondopeptidases, their preparation and use. |
| CN102234249B (zh) * | 2010-04-23 | 2013-08-28 | 首都医科大学 | N-(六氢嘧啶-1,3-二基)-二-l-氨基酸甲酯及其制备方法和应用 |
| AU2011261375B2 (en) | 2010-06-04 | 2016-09-22 | Albany Molecular Research, Inc. | Glycine transporter-1 inhibitors, methods of making them, and uses thereof |
| KR101822417B1 (ko) * | 2017-06-14 | 2018-01-29 | 주식회사 청도제약 | 인간의 체액에서 산화 스트레스를 측정하기 위한 방법 |
| KR102432016B1 (ko) | 2020-07-31 | 2022-08-16 | 부산대학교 산학협력단 | 신경염증질환 예방 또는 치료용 조성물 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2078323A (en) * | 1937-04-27 | C-amino-substituted barbituric | ||
| US2084136A (en) * | 1933-06-03 | 1937-06-15 | Heyden Chem Fab | Barbituric acid containing in the 5-position a pyridine group and method of preparing the same |
| DE763145C (de) * | 1942-05-29 | 1954-05-03 | Chem Fab Von Heyden A G | Verfahren zur Herstellung von 5-AEthyl-5-piperidinobarbitursaeure |
| US3930006A (en) * | 1963-04-30 | 1975-12-30 | Aspro Nicholas Ltd | Antiparkinsonism compositions and method |
| DE1246743B (de) * | 1965-01-12 | 1967-08-10 | Dresden Arzneimittel | Verfahren zur Herstellung von 5-Phenyl-5-piperidinobarbitursaeuren |
| DE19726427A1 (de) * | 1997-06-23 | 1998-12-24 | Boehringer Mannheim Gmbh | Pyrimidin-2,4,6-trion-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
-
1995
- 1995-12-23 DE DE19548624A patent/DE19548624A1/de not_active Withdrawn
-
1996
- 1996-12-20 EP EP96944612A patent/EP0869947B1/en not_active Expired - Lifetime
- 1996-12-20 KR KR10-1998-0704855A patent/KR100440035B1/ko not_active IP Right Cessation
- 1996-12-20 HU HU9901065A patent/HUP9901065A3/hu unknown
- 1996-12-20 NZ NZ325802A patent/NZ325802A/xx unknown
- 1996-12-20 WO PCT/EP1996/005766 patent/WO1997023465A1/en active IP Right Grant
- 1996-12-20 BR BR9612232A patent/BR9612232A/pt not_active IP Right Cessation
- 1996-12-20 AT AT96944612T patent/ATE226575T1/de not_active IP Right Cessation
- 1996-12-20 PL PL96327466A patent/PL190217B1/pl not_active IP Right Cessation
- 1996-12-20 PT PT96944612T patent/PT869947E/pt unknown
- 1996-12-20 CZ CZ19981968A patent/CZ292503B6/cs not_active IP Right Cessation
- 1996-12-20 US US09/091,352 patent/US6110924A/en not_active Expired - Fee Related
- 1996-12-20 ZA ZA9610765A patent/ZA9610765B/xx unknown
- 1996-12-20 JP JP52331897A patent/JP4198752B2/ja not_active Expired - Fee Related
- 1996-12-20 IL IL12504896A patent/IL125048A/en not_active IP Right Cessation
- 1996-12-20 DK DK96944612T patent/DK0869947T3/da active
- 1996-12-20 CN CNB961800275A patent/CN1318406C/zh not_active Expired - Fee Related
- 1996-12-20 DE DE69624500T patent/DE69624500T2/de not_active Expired - Fee Related
- 1996-12-20 ES ES96944612T patent/ES2184903T3/es not_active Expired - Lifetime
- 1996-12-20 RU RU98113916/04A patent/RU2177475C2/ru not_active IP Right Cessation
-
1997
- 1997-01-28 TW TW086101091A patent/TW518324B/zh not_active IP Right Cessation
-
1998
- 1998-06-22 NO NO19982901A patent/NO311572B1/no unknown
- 1998-06-22 MX MX9805063A patent/MX9805063A/es not_active IP Right Cessation
-
2000
- 2000-06-16 US US09/594,700 patent/US6472396B1/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9805063A (es) | Nuevos derivados de acido barbiturico, procesos para su produccion y agentes farmaceuticos que contienen estos compuestos. | |
| DE3167757D1 (en) | Dibenz(b,f)(1,4)oxazepine derivatives, process for preparing the same, and pharmaceutical compositions comprising the same | |
| ATE176664T1 (de) | 2-propylvaleriansäure und 2-propylvalerian- säureamid-derivate und deren verwendung als antikonvulsive mittel | |
| IL104305A0 (en) | Piperazine derivatives,their preparation and pharmaceutical compositions containing them | |
| CO5690561A2 (es) | Administracion oral de acido [2-(8,9-dioxo-2,6-diazabiciclo[5.2.0]non-1(7)-en-2-il)alquil]fosfonico y derivados | |
| HUP9802323A2 (hu) | Pirimidinszármazékok, eljárás előállításukra és az ezeket tartalmazó gyógyászati készítmények | |
| MY122255A (en) | Acrylonitrile compounds, process for their production and pesticides containing them | |
| DK0488897T3 (da) | Guanidinderivater, fremgangsmåde til fremstilling heraf samt farmaceutiske midler indeholdende disse | |
| BE901239A (fr) | Nouveaux derives d'aminoguanidine et procede pour leur preparation. | |
| ATE53032T1 (de) | 2-thiazolylimidazo(1,2-a)pyrimidine und ihre salze, verfahren zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen. | |
| DK0553016T3 (da) | Hidtil ukendte naphtalenamider og -sulfonamider, fremgangsmåder til deres fremstilling samt farmaceutiske midler indeholdende dem | |
| CA2240845A1 (en) | New barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds | |
| NZ240051A (en) | Prodrugs of sertindole; pharmaceutical compositions and preparatory processes | |
| AR027578A1 (es) | Derivados de indano | |
| MX9303990A (es) | Tetrazolil (fenoxi y fenoxialquil) piperidinil piridazinas como agentes antivirales. | |
| IL106356A (en) | 4-amino-n-(4-methyl- 4-piperidinyl)- 2-methoxybenzamides, their preparation and pharmaceutical compositions containing them | |
| SE8207092L (sv) | Forfarande for framstellning av optiskt aktiva penemer | |
| FR2441617A1 (fr) | Nouveaux derives de s-triazine, leur procede de preparation et compositions pharmaceutiques les contenant | |
| ATE173460T1 (de) | O-acyl-4-phenyl-cyclohexanole, deren salze, diese verbindungen enthaltende arzneimittel und deren verwendung sowie verfahren zu ihrer herstellung | |
| PT84680A (fr) | Procede de preparation de derives 1,5-benzothiazepine et de compositions pharmaceutiques les contenant | |
| BE900556A (fr) | Nouveau procede de preparation d'antibiotiques du type cephalosporine. | |
| NO963374L (no) | Substituerte 4H-pyraner | |
| IL116646A (en) | Antifungal fusacandins, process for their preparation, pharmaceutical compositions containing them and uses thereof | |
| ES269845A1 (es) | Procedimiento para la preparacion de heterociclos basicamente sustituidos | |
| NZ315347A (en) | Heterocyclic compounds for treating myocardial ischaemia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| MM | Annulment or lapse due to non-payment of fees |